Astera Labs Inc (ALAB) concluded trading on Thursday at a closing price of $123.73, with 6.12 million shares of worth about $756.68 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 135.18% during that period and on January 23, 2025 the price saw a gain of about 0.63%. Currently the company’s common shares owned by public are about 158.56M shares, out of which, 116.41M shares are available for trading.
Stock saw a price change of -6.10% in past 5 days and over the past one month there was a price change of -1.24%. Over the period of past 52 weeks, stock dropped to lowest price of $36.22 but also hit the highest price of $147.39 during that period. The average intraday trading volume for Astera Labs Inc shares is 4.85 million. The stock is currently trading -7.19% below its 20-day simple moving average (SMA20), while that difference is up 4.08% for SMA50 and it goes to 66.54% higher than SMA200.
Astera Labs Inc (NASDAQ: ALAB) currently have 158.56M outstanding shares and institutions hold larger chunk of about 46.38% of that.
The stock has a current market capitalization of $19.62B. It has posted earnings per share of -$0.60 in the same period. It has Quick Ratio of 10.46 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALAB, volatility over the week remained 8.54% while standing at 6.35% over the month.
Analysts are in expectations that Astera Labs Inc (ALAB) stock would likely to be making an EPS of 0.26 in the current quarter, while forecast for next quarter EPS is 0.25 and it is 1.16 for next year. For the current quarter EPS, analysts have given the company a lowest target 0.25 which is 0.27 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 701.35% while it is estimated to increase by 61.32% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on January 21, 2025 offering an Equal-weight rating for the stock and assigned a target price of $142 to it. Coverage by Northland Capital stated Astera Labs Inc (ALAB) stock as a Market perform in their note to investors on January 02, 2025, suggesting a price target of $120 for the stock. On November 18, 2024, Citigroup Initiated their recommendations, while on September 04, 2024, Morgan Stanley Upgrade their ratings for the stock with a price target of $55. Stock get an Outperform rating from Evercore ISI on April 16, 2024.
